Mesa Laboratories, Inc.
Price Action
Technical Summary
STAGE 2 UPTRENDMesa Laboratories, Inc. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is moderate (RS Rating: 79), indicating performance broadly in line with the market. Earnings growth of 310% provides fundamental context to the price action. Investors should exercise caution due to high volatility (60% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $99.94 | +6.02% | ABOVE |
| 50 SMA | $91.71 | +15.54% | ABOVE |
| 100 SMA | $88.31 | +19.98% | ABOVE |
| 150 SMA | $83.90 | +26.29% | ABOVE |
| 200 SMA | $79.92 | +32.58% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is MLAB in an uptrend right now?
MLAB has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, MLAB is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is MLAB overbought or oversold?
MLAB's RSI (14) is 63. The stock is in neutral territory, neither overbought nor oversold.
Is MLAB outperforming the market?
MLAB has a Relative Strength (RS) Rating of 79 out of 99. MLAB is performing about average compared to the market.
Where is MLAB in its 52-week range?
MLAB is trading at $105.95, which is 81% of its 52-week high ($131.20) and 67% above its 52-week low ($55.45).
How volatile is MLAB?
MLAB has a Beta of 1.78 and 52-week volatility of 60%. It's more volatile than the S&P 500 - expect bigger swings.